Christopher R. Cowles
Corporate Officer/Principal chez State of Massachusetts
Profil
Christopher R.
Cowles is a professional with experience in various firms and educational institutions.
He is currently a Member at the State of Massachusetts.
Previously, he worked as a Director-Intellectual Property at Dicerna Pharmaceuticals, Inc. and as an Associate at Edwards Angell Palmer & Dodge LLP.
He obtained his undergraduate degree from Rice University, graduate degree from Suffolk University, and doctorate from the University of California San Diego.
Postes actifs de Christopher R. Cowles
| Sociétés | Poste | Début |
|---|---|---|
| State of Massachusetts | Corporate Officer/Principal | - |
Anciens postes connus de Christopher R. Cowles
| Sociétés | Poste | Fin |
|---|---|---|
Edwards Angell Palmer & Dodge LLP
 Edwards Angell Palmer & Dodge LLP Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Edwards Angell Palmer & Dodge LLP is a law firm that manages private portfolios for high net-worth individuals. The firm is headquartered in Boston with offices throughout the US and in the UK and Hong Kong. | Corporate Officer/Principal | - |
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Christopher R. Cowles
| Rice University | Undergraduate Degree |
| Suffolk University | Graduate Degree |
| University of California San Diego | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
| State of Massachusetts | Government |
Edwards Angell Palmer & Dodge LLP
Edwards Angell Palmer & Dodge LLP Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Edwards Angell Palmer & Dodge LLP is a law firm that manages private portfolios for high net-worth individuals. The firm is headquartered in Boston with offices throughout the US and in the UK and Hong Kong. | Commercial Services |
